Management changes at Abliva
Lund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018.
ADVERTISEMENT
About Michael Kuhrt
This author has not written his bio yet.
But we are proud to say that Michael Kuhrt contributed 541 entries already.
Entries by Michael Kuhrt
Swedish AlzeCure appoints CMO
Märta Segerdahl will take over the position as Chief Medical Officer of Swedish AlzeCure Pharma AB on April.
Accure Therapeutics named new CMO
Spanish Accure Therapeutics appoints Dr Rossella Medori as new Chief Medical officer.
Clariant new year, new CEO
Muttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer,
Transgene starts 2021 with a new CEO
Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer.
Apaxen S.A. appoints CEO
Bart Wuurman joined the young Belgian biotechnology company Apaxen S.A. in November as new CEO.
Harmonisation of patent law without the UPC?
Hague Court of Appeal (CoA) sets Dutch approach to the doctrine equivalence reversing District Court, handing Eli Lilly another win in its pan-European battle over infringement of its pemetrexed patents and bringing it in line with approaches taken elsewhere in Europe like in Germany and in the UK.
New at Polyplus-transfection
French Polyplus-transfection SA named Mario Philips as new CEO. He succeeds Karsten Wilking, now a Strategic Advisor of the biotech company, specialist for innovative transfection solutions to support the gene and cell therapy market.
Women’s health from niche to mainstream
Women make up half of the world’s population. Finally, pharma companies and invetors are now beginning to pay more attention to female diseases.
Urgent need for medical data network across borders
The COVID-19 pandemic is putting our health systems in Europe to the test. Capacity bottlenecks are becoming apparent, as are long-neglected investments in modern infrastructure. As the pandemic does not stop at national borders, cross-border healthcare solutions are more urgent than ever.